EMEA (Europe, Middle East and Africa) Single Use Technologies for Biopharmaceuticals Market Report 2018

SKU ID : QYR- 11863951

Publishing Date : 22-Jun-2018

No. of pages : 102

PRICE
4000
8000


  • In this report, the EMEA Single Use Technologies for Biopharmaceuticals market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

    Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Single Use Technologies for Biopharmaceuticals for these regions, from 2013 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

    EMEA Single Use Technologies for Biopharmaceuticals market competition by top manufacturers/players, with Single Use Technologies for Biopharmaceuticals sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    EMD Millipore
    GE Healthcare
    Pall Corp
    Sartorius Stedim Biotech
    Thermo Fisher
    ...

    On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Single-use Bioreactors
    Membrane Adsorbers
    Media Bags
    Bioprocess Containers
    Others

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Contract Manufacturing Organizations
    Biopharmaceutical Manufacturers